Amarin Corporation plc - Special Call Transcript
Welcome to Amarin Corporation's American Heart Association Scientific Sessions wrap-up event where select scientific publications presented over the weekend will be discussed. This conference call is being recorded today, November 18, 2020.
I will now turn the conference call over to Alina Kolomeyer, Director of Communications at Amarin.
Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT, presented to the medical community at the American Heart Association Virtual Scientific Sessions 2020.
Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act. Examples of such statements include, but are not limited to, our current expectations regarding VASCEPA clinical data and expectation regarding the application of these data to clinical use, in reimbursement and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |